Abound Wealth Management Dr Reddys Laboratories LTD Transaction History
Abound Wealth Management
- $301 Billion
- Q3 2024
A detailed history of Abound Wealth Management transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Abound Wealth Management holds 25 shares of RDY stock, worth $377. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25
Previous 18
38.89%
Holding current value
$377
Previous $1.37 Million
44.83%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding RDY
# of Institutions
233Shares Held
24.1MCall Options Held
14.6KPut Options Held
2.8K-
Robeco Institutional Asset Management B.V.2.07MShares$31.2 Million0.33% of portfolio
-
Royal Bank Of Canada Toronto, A62.06MShares$31 Million0.04% of portfolio
-
Morgan Stanley New York, NY2.03MShares$30.6 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2MShares$30.1 Million0.27% of portfolio
-
Black Rock Inc. New York, NY1.8MShares$27.2 Million0.0% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.51B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...